Doctor on Demand was founded in 2012 by Phil McGraw, Jay McGraw, and Adam Jackson. The company has not officially endorsed a plan to participate in an IPO.
Doctor on Demand operates a mobile-first platform intended to connect patients to board-certified physicians allowing the latter to conduct real-time video medical and mental health consultations. The company has raised nearly $250 million in Venture Capital funding from investors including General Atlantic, Alpha Venture Partners, Blue Cloud Ventures, Venrock, Shasta Ventures, Lerer Hippeau, GV, Andreessen Horowitz, Tenaya Capital, and Qualcomm Ventures. Per company press releases, Doctor on Demand last raised $75 million in July 2020 at a post-money valuation of over $800 million.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
07/08/2020 | Series D | $78.74MM | $xx.xx | $820.61MM | General Atlantic | |
Price per Share
$xx.xx
Shares Outstanding
2,760,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
General Atlantic
|
||||||
04/27/2018 | Series C | $74MM | $xx.xx | $299.23MM | Blue Cloud Ventures, Goldman Sachs Investment Partners, Lerer Hippeau Ventures, Princeville Global, Qualcomm Ventures, Richard Branson, Ridgeview Asset Management, Shasta Ventures, Sherpa Capital, Tenaya Capital, Venrock, World Innovation Lab | |
Price per Share
$xx.xx
Shares Outstanding
5,887,898
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Blue Cloud Ventures, Goldman Sachs Investment Partners, Lerer Hippeau Ventures, Princeville Global, Qualcomm Ventures, Richard Branson, Ridgeview Asset Management, Shasta Ventures, Sherpa Capital, Tenaya Capital, Venrock, World Innovation Lab
|
||||||
07/20/2015 | Series B | $62.75MM | $xx.xx | $286.5MM | 23andme, Benjamin Boyer, Dignity Health, Jump Capital, Qualcomm Ventures, Richard Branson, Rock Health, Rosemark Capital Group, Shasta Ventures, Sherpa Capital, Tenaya Capital, Venrock, Virgin.Com, World Innovation Lab | |
Price per Share
$xx.xx
Shares Outstanding
3,838,066
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
23andme, Benjamin Boyer, Dignity Health, Jump Capital, Qualcomm Ventures, Richard Branson, Rock Health, Rosemark Capital Group, Shasta Ventures, Sherpa Capital, Tenaya Capital, Venrock, Virgin.Com, World Innovation Lab
|
||||||
08/06/2014 | Series A-2 | $21MM | $xx.xx | $140MM | Richard Branson, Shasta Ventures, Tomorrowventures, Venrock | |
Price per Share
$xx.xx
Shares Outstanding
2,319,490
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Richard Branson, Shasta Ventures, Tomorrowventures, Venrock
|
||||||
01/01/2013 | Series A-1 | $3.17MM | $xx.xx | $20MM | Andreessen Horowitz, Ellenlevy & Other Individual Investors, Gv, Iseed Ventures, Lerer Hippeau Ventures, Shasta Ventures | |
Price per Share
$xx.xx
Shares Outstanding
1,735,997
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Andreessen Horowitz, Ellenlevy & Other Individual Investors, Gv, Iseed Ventures, Lerer Hippeau Ventures, Shasta Ventures
|